Literature DB >> 11668323

Acute mesenteric venous thrombosis: case for nonoperative management.

L Brunaud1, L Antunes, S Collinet-Adler, F Marchal, A Ayav, L Bresler, P Boissel.   

Abstract

OBJECTIVE: Initial treatment in the management of acute mesenteric vein thrombosis (MVT) is controversial. Some authors have proposed a surgical approach, whereas others have advocated medical therapy (anticoagulation). In this study, we analyzed and compared the results obtained with surgical and medical treatment to determine the best initial management for this disease.
METHODS: We retrospectively reviewed the records of patients treated for MVT in a secondary care surgical department from January 1987 to December 1999. Before January 1995, our departmental policy was to perform surgery in patients with suspected MVT. Since January 1995, we have preferred a medical approach when achievable. Each patient in this study was assessed for diagnosis, initial management (laparotomy or anticoagulation), morbidity, mortality, duration of hospitalization, the need for secondary operation, portal hypertension, and survival rates.
RESULTS: Twenty-six patients were treated, 14 before January 1995 (group 1) and 12 since January 1995 (group 2). Morbidity, mortality, secondary operation, portal hypertension, and 2-year survival rates were 34.6%, 19.2%, 15.3%, 19.2%, and 76.9%, respectively. No statistical difference was observed between the two groups. The mean duration of hospitalization was 51.6 days in group 1 and 23.2 days in group 2 (P < .05). Among the 12 patients treated by means of laparotomy with bowel resection, 10 patients (83%) had mucosal necrosis without transmural necrosis at pathologic study.
CONCLUSION: Nonoperative management for acute MVT is feasible when the initial diagnosis with a computed tomography scan is certain and when the bowel infarction has not led to transmural necrosis and bowel perforation. The morbidity, mortality, and survival rates are similar in cases of surgical and nonoperative management. The length of hospital stay is shorter when patients are treated with a nonoperative approach. A nonoperative approach, when indicated, avoids the resection of macroscopically infarcted small bowel (without transmural necrosis) in cases that are potentially reversible with anticoagulation alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668323     DOI: 10.1067/mva.2001.117331

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  43 in total

1.  Portomesenteric venous thrombosis following major colon and rectal surgery: incidence and risk factors.

Authors:  Kristin A Robinson; Mark E O'Donnell; David Pearson; J Scott Kriegshauser; Melanie Odeleye; Kristen Kalkbrenner; Zachary Bodnar; Tonia M Young-Fadok
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

2.  Predictive Factors of Intestinal Necrosis in Acute Mesenteric Ischemia: Prospective Study from an Intestinal Stroke Center.

Authors:  Alexandre Nuzzo; Leon Maggiori; Maxime Ronot; Aymeric Becq; Aurelie Plessier; Nathalie Gault; Francisca Joly; Yves Castier; Valerie Vilgrain; Catherine Paugam; Yves Panis; Yoram Bouhnik; Dominique Cazals-Hatem; Olivier Corcos
Journal:  Am J Gastroenterol       Date:  2017-03-07       Impact factor: 10.864

3.  Surgical and medical management of mesenteric ischemia.

Authors:  Juergen Falkensammer; Warner Andrew Oldenburg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

4.  Splenic and superior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis.

Authors:  Najib Safieddine; Joseph Mamazza; Andrew Common; Vikram Prabhudesai
Journal:  Can J Surg       Date:  2007-02       Impact factor: 2.089

5.  Mesenteric venous thrombosis and factors associated with mortality: a statistical analysis with five-year follow-up.

Authors:  S Abu-Daff; N Abu-Daff; M Al-Shahed
Journal:  J Gastrointest Surg       Date:  2009-03-19       Impact factor: 3.452

6.  Acute extensive portal and mesenteric venous thrombosis after splenectomy: treated by interventional thrombolysis with transjugular approach.

Authors:  Mao-Qiang Wang; Han-Ying Lin; Li-Ping Guo; Feng-Yong Liu; Feng Duan; Zhi-Jun Wang
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

7.  The role of heparin in a warfarinized patient with mesenteric venous thrombosis.

Authors:  Dwayne Tun Soong Chang; Jacinta Cover; Hajir Nabi; David Bartolo
Journal:  Int J Colorectal Dis       Date:  2015-07-07       Impact factor: 2.571

8.  Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes.

Authors:  Paras Karmacharya; Madan Raj Aryal; Anthony Donato
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Findings in multi-detector row CT with portal phase enhancement in patients with mesenteric venous thrombosis.

Authors:  S Acosta; A Alhadad; O Ekberg
Journal:  Emerg Radiol       Date:  2009-03-18

10.  Predictors of irreversible intestinal resection in patients with acute mesenteric venous thrombosis.

Authors:  Shi-Long Sun; Xin-Yu Wang; Cheng-Nan Chu; Bao-Chen Liu; Qiu-Rong Li; Wei-Wei Ding
Journal:  World J Gastroenterol       Date:  2020-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.